Ligand Pharma (LGND) PT Raised to $340 at RBC Capital
Tweet Send to a Friend
(Updated - July 15, 2026 9:55 AM EDT)
RBC Capital analyst Douglas Miehm raised the price target on Ligand ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Douglas Miehm raised the price target on Ligand ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
